The Importance Of Supply Chain, Manufacturing Resilience In Pandemic Response
Source: Bioprocess Online
In this segment of the BioProcess Online Live event The Next Pandemic: Biopharma's Opportunities and Obligations, Heat Biologics Founder & CEO Jeff Wolf, Massachusetts Biomedical Initiatives President & CEO Jon Weaver, and Lakes BioScience Chief Strategy and Technology Officer Adrian Wallis discuss how public/private partnerships play a key role in building resilience and security in biopharma supply chains and manufacturing capacity.
View the full presentation on-demand here.
This website uses cookies to ensure you get the best experience on our website. Learn more